You are not currently logged in.
Access your personal account or get JSTOR access through your library or other institution:
If You Use a Screen ReaderThis content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Benefits Due to Immunization against Measles
Norman W. Axnick, Steven M. Shavell and John J. Witte
Public Health Reports (1896-1970)
Vol. 84, No. 8 (Aug., 1969), pp. 673-680
Published by: Association of Schools of Public Health
Stable URL: http://www.jstor.org/stable/4593651
Page Count: 8
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Preview not available
The immunization effort against measles in the United States was initiated in 1963. It has resulted in a sharp decrease in incidence of the disease--from 4 million cases in 1963 to one quarter of a million cases in 1968--and in associated costs. A study by researchers of the National Communicable Disease Center shows that during the years 1963 through 1968 the immunization effort is estimated to have averted 9.7 million acute cases of measles and 3,244 cases of mental retardation. It also is estimated to have saved 973 lives, 555,000 hospital days, 291,000 years of normal life, more than 1.6 million workdays, 32 million schooldays, and $423 million. About nine-tenths of the savings in each of these categories has been realized in the last 3 years--the period of intensive national effort to eradicate measles.
Public Health Reports (1896-1970) © 1969 Association of Schools of Public Health